BillsSS. 4472

Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026

119th CongressIntroduced April 30, 2026Sen. Murkowski, Lisa [R-AK]· AK
Stage
In other chamber
Latest action
Held at the desk.
August 10, 2026

Summary

Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026 This bill reauthorizes through FY2031 and revises programs that support research and development of drugs and other

Committees

  • PrimaryHealth, Education, Labor, and Pensions Committee

CRS subjects

Department of Health and Human ServicesDrug therapyFood and Drug Administration (FDA)

Action history

  1. April 30, 2026Introduced in Senate
  2. April 30, 2026Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
  3. June 17, 2026Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.
  4. July 16, 2026Committee on Health, Education, Labor, and Pensions. Reported by Senator Cassidy with an amendment in the nature of a substitute. Without written report.
  5. July 16, 2026Committee on Health, Education, Labor, and Pensions. Reported by Senator Cassidy with an amendment in the nature of a substitute. Without written report.
  6. July 16, 2026Placed on Senate Legislative Calendar under General Orders. Calendar No. 461.
  7. August 4, 2026Passed/agreed to in Senate: Passed Senate with an amendment by Voice Vote.
  8. August 4, 2026Passed Senate with an amendment by Voice Vote. (consideration: CR S4425-4426; text: CR S4425-4426)
  9. August 10, 2026Message on Senate action sent to the House.
  10. August 10, 2026Received in the House.
  11. August 10, 2026Held at the desk.

Cosponsors (15)

Text versions

Related bills

  • H.R. 8205related
    Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026